VYNE Therapeutics (VYNE) Gross Profit (2019 - 2021)
VYNE Therapeutics (VYNE) posted Gross Profit of -$630000.0 for Q4 2021, up 31.22% on a QoQ basis from -$916000.0 in Q3 2021, and down 116.79% year-over-year from $3.8 million in Q4 2020.
VYNE Therapeutics (VYNE) Gross Profit (2019 - 2021) Analysis & Trends
VYNE Therapeutics' Gross Profit history runs 3 years deep, the most recent figure standing at -$630000.0 for Q4 2021.
- Quarterly Gross Profit fell 116.79% year-over-year to -$630000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$2.4 million (down 112.33% YoY) and the FY2021 annual result came in at -$2.4 million, down 112.33% from the prior year.
- Gross Profit was -$630000.0 for Q4 2021 at VYNE Therapeutics, up from -$916000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $11.5 million in Q2 2020 and bottomed at -$916000.0 in Q3 2021.
- A 3-year average of $1.9 million and a median of $135000.0 in 2019 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2020 — Gross Profit surged 2679.26% — and 2021, when it sank 131.61%.
- VYNE Therapeutics' Gross Profit stood at $135000.0 in 2019, then jumped by 2679.26% to $3.8 million in 2020, then plunged by 116.79% to -$630000.0 in 2021.
- Business Quant data shows VYNE's Gross Profit at -$630000.0 in Q4 2021, -$916000.0 in Q3 2021, and -$500000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -630,000.00 |
| Dec 31, 2021 | -630,000.00 |
| Sep 30, 2021 | -916,000.00 |
| Sep 30, 2021 | -916,000.00 |
| Jun 30, 2021 | -500,000.00 |
| Jun 30, 2021 | -500,000.00 |
| Mar 31, 2021 | -371,000.00 |
| Mar 31, 2021 | -371,000.00 |
| Dec 31, 2020 | 3.75 Mn |
| Dec 31, 2020 | 3.75 Mn |
| Sep 30, 2020 | 2.90 Mn |
| Sep 30, 2020 | 2.90 Mn |
| Jun 30, 2020 | 11.47 Mn |
| Jun 30, 2020 | 11.47 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 135,000.00 |
| Dec 31, 2019 | 135,000.00 |